Clinical trials of the AstraZeneca vaccine are still in progress.
Copyright 2020 The Associated Press. All Rights Reserved
Swiss drug authority Swissmedic has begun evaluating the so-called “Covid-19 Vaccine AstraZeneca”. It is the first time that a drugmaker has presented a coronavirus vaccine for approval in Switzerland.
AstraZeneca, which developed the vaccine in collaboration with the University of Oxford, submitted its application to Swissmedic at the start of this month.
The vaccine’s scientific evaluation will be done via a “rolling submission” process. This allows a pharmaceutical company to launch the application procedure before a product’s development is complete.
This “enables Swissmedic to carry out the scientific assessment of non-clinical data from laboratory tests while clinical trials are still in progress,” announced Swissmedic in a statement on Tuesday, noting that trial results must be submitted for scientific review as they become available over the next weeks and months.
More
More
Half of Swiss would get vaccinated against Covid-19
This content was published on
If there were an efficient vaccination against coronavirus, every second person in Switzerland would take it, says a survey.
“However, no decision on authorisation can be taken until all the data needed to assess the safety, quality and efficacy of the vaccine have been submitted. The documentation must demonstrate how safe and effective the vaccine is in protecting humans against the new SARS-CoV-2 coronavirus,” wrote the Swiss drug authority.
Swissmedic noted that while it is reviewing the vaccine independently, it is also working closely with partner authorities abroad. No medicinal product can go onto the Swiss market without Swissmedic’s approval.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
Too much light at night disturbs great tits when breeding
This content was published on
Great tits have fewer young in nesting boxes in the city than in forests. The reason for this is light pollution, according to a Swiss study.
Psychologists: big break in relationships comes one to two years before separation
This content was published on
Many people ask themselves whether their relationship will last. A clear sign exists that it could soon be over, according to an analysis with Swiss participation.
This content was published on
The train line between Täsch and Zermatt in southwestern Switzerland was interrupted again on Wednesday morning by another rockfall.
New counter-proposal launched for initiative to halve Swiss licence fee
This content was published on
Swiss companies are to be completely exempt from the licence fee until 2035. In return, households should continue to pay CHF335 ($380) a year, recommends a parliamentary committee.
Swiss carry out record number of civilian service days
This content was published on
Members of the civilian service completed a record 1.9 million days of service in 2024, a 3.5% increase on the previous year.
Initiative aims to curb lobbying in Swiss parliament
This content was published on
A new popular initiative wants to put the brakes on lobbying in federal politics. Members of the Federal Assembly with vested interests are the target.
Switzerland pre-orders 4.5 million doses of Covid-19 vaccine
This content was published on
The Swiss government has signed a deal with US biotech firm Moderna to secure early access to 4.5 million doses of a Covid-19 vaccine currently in development.
Switzerland fast-tracks antiviral medication against Covid-19
This content was published on
Swissmedic, the agency that oversees the use of medicaments in Switzerland, took days to fast-track approval of the drug, which is produced under the brand name Veklury by US biopharmaceutical company Gilead Sciences. The application for its extended use was only received on Monday. It can now be used for a limited period of time to…
Join the conversation!